Tag: CBT > DEA Cannabis Policy and Legalization: Page 4

Cannabis Rescheduling

Former US Attorneys Urge Federal Officials to Reject Cannabis Rescheduling Recommendation

Eric Berlin, partner at Dentons, shares insight into some of the arguments the 29 former attorneys make against removing cannabis from Schedule I of the Controlled Substances Act.

December 21, 2023

Georgia

‘We Won’t Stop Working for Patient Access’: Georgia Regulators Weigh Options After Receiving DEA Warning About Pharmacies Dispensing Medical Cannabis

Georgia Access to Medical Cannabis Commission members said during a Dec. 13 meeting that the DEA’s recent warning highlights conflicting federal and state cannabis policy and they plan to continue fighting for patient access.

December 14, 2023

Ohio

The Top 10: CBT's Most-Read Articles in November

Here's a recap and list of the stories readers engaged most with this month.

November 29, 2023

Cannabis Rescheduling

US Sen. Kirsten Gillibrand Calls on DEA to Reclassify Cannabis as Schedule III

The New York Democrat says cannabis “is simply not comparable to other Schedule I substances like heroin, LSD and MDMA.”

November 21, 2023

Cannabis Rescheduling

31 Bipartisan House Lawmakers Urge DEA to End ‘Failed’ Cannabis Prohibition

A group of U.S. representatives sent a letter to DEA Administrator Anne Milgram calling on her agency to “recognize the merits of full descheduling.”

November 1, 2023

Tomorrow in Cannabis

The Story of My Cannabis Arrest

30 years ago, Kenneth Morrow was arrested for commercial cannabis cultivation and sale. Here he details his experience and how the legal landscape in California—and the U.S.—has evolved.

October 23, 2023

Cannabis Rescheduling

Rescheduling Cannabis: Would 1961 Drug Treaty Be a Possible Wrench?

Reclassifying cannabis to a Schedule III drug would put the U.S. in noncompliance with the international treaty Single Convention on Narcotic Drugs, 1961. Will this create a barrier for the U.S. in its scheduling review, and if so, to what extent? Historian James H. Mills weighs in.

October 5, 2023

Cannabis Industry Research

The Impacts of Cannabis Rescheduling: Panelists Weigh In During International Cannabis Bar Association Webinar

Industry legal experts Khurshid Khoja, Amber Littlejohn and Shane Pennington shared insight into what rescheduling could mean for taxes, research and federal enforcement.

September 12, 2023

Hemp Regulations in U.S.

DEA May Propose Regulations That Would Threaten the Hemp-Derived Cannabinoid Industry and Cast a Dark Cloud Over CBD Industry

The federal agency announced in early May that it plans to soon propose new rules that would classify synthetically derived cannabinoids as controlled substances and would decontrol CBD up to 0.1% THC on a weight-to-weight or weight-to-volume basis.

May 26, 2023

Videos

Cannabis Seeds Are Federally Legal: What Now?

Following the January 2022 DEA acknowledgement that cannabis seeds are federally "legal" under the 2018 Farm Bill, we attempt to clarify precisely what that means in this webinar.

February 2, 2023

Illinois

Genetics Storefront Opens Doors in Chicago After DEA Deems Cannabis Seeds Legal

MoneyTree Genetics is selling seeds and clones to the public and to Illinois cannabis businesses and patients enrolled in the state’s medical cannabis program.

January 23, 2023

Legislation and Regulation

National Industrial Hemp Council Urges FDA to Approve Hemp Seed for Animal Feed

The NIHC sent a letter to the FDA, calling for the federal agency to approve hemp seed as a viable feed alternative for livestock producers.

November 7, 2022